Literature DB >> 22472645

Effects of donor characteristics and ex vivo expansion on canine mesenchymal stem cell properties: implications for MSC-based therapies.

Susan W Volk1, Yanjian Wang, Kurt D Hankenson.   

Abstract

Clinical trials utilizing bone marrow-derived mesenchymal stem cell (BM-MSC) therapies show promise for treating a variety of pathologic conditions. Paramount to optimization of such cell-based therapies is a thorough understanding of MSC biology. Despite the tremendous potential that exists for the clinical use of canine BM-MSCs in veterinary medicine, as well as in preclinical studies for human medicine, relatively little information exists regarding basic biological properties of the cells. In this study, we compared the importance of donor characteristics (age and harvest site) and ex vivo expansion on canine BM-MSC frequency (CFU-f) and differentiation potential. Advancing age was found to have a negative effect on CFU-f as well as osteogenic potential. Site of harvest was also found to have significant effects on MSC properties. MSCs obtained from the humerus were found at the lowest frequency and were least osteogenic compared to those harvested from the tibia, femur, and ilium. Osteogenic potential diminished significantly by the third passage. These results suggest important donor parameters and culture effects to consider in translational studies examining MSC-based regenerative medical strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22472645      PMCID: PMC3840229          DOI: 10.3727/096368912X636821

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  51 in total

1.  Isolation, characterization, and differentiation potential of canine adipose-derived stem cells.

Authors:  N M Vieira; V Brandalise; E Zucconi; M Secco; B E Strauss; M Zatz
Journal:  Cell Transplant       Date:  2009-12-08       Impact factor: 4.064

2.  Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation.

Authors:  S P Bruder; N Jaiswal; S E Haynesworth
Journal:  J Cell Biochem       Date:  1997-02       Impact factor: 4.429

3.  Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells.

Authors:  Santiago Roura; Jordi Farré; Carolina Soler-Botija; Anna Llach; Leif Hove-Madsen; Jordi J Cairó; Francesc Gòdia; Juan Cinca; Antoni Bayes-Genis
Journal:  Eur J Heart Fail       Date:  2006-02-28       Impact factor: 15.534

4.  Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury.

Authors:  Florian Tögel; Arthur Cohen; Ping Zhang; Ying Yang; Zhuma Hu; Christof Westenfelder
Journal:  Stem Cells Dev       Date:  2009-04       Impact factor: 3.272

5.  Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O.

Authors:  J L Ramírez-Zacarías; F Castro-Muñozledo; W Kuri-Harcuch
Journal:  Histochemistry       Date:  1992-07

6.  Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.

Authors:  Melissa A Baxter; Robert F Wynn; Simon N Jowitt; J Ed Wraith; Leslie J Fairbairn; Ilaria Bellantuono
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

7.  Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells.

Authors:  Li-Bo Chen; Xiao-Bing Jiang; Lian Yang
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

8.  Derivation, characterization, and in vitro differentiation of canine embryonic stem cells.

Authors:  Brian Hayes; Sara R Fagerlie; Aravind Ramakrishnan; Szczepan Baran; Michael Harkey; Lynn Graf; Merav Bar; Ausra Bendoraite; Muneesh Tewari; Beverly Torok-Storb
Journal:  Stem Cells       Date:  2007-12-06       Impact factor: 6.277

9.  Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair.

Authors:  R G Young; D L Butler; W Weber; A I Caplan; S L Gordon; D J Fink
Journal:  J Orthop Res       Date:  1998-07       Impact factor: 3.494

10.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

Authors:  Ralf Hass; Cornelia Kasper; Stefanie Böhm; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2011-05-14       Impact factor: 5.712

View more
  18 in total

1.  Focal enhancement of the skeleton to exercise correlates with responsivity of bone marrow mesenchymal stem cells rather than peak external forces.

Authors:  Ian J Wallace; Gabriel M Pagnotti; Jasper Rubin-Sigler; Matthew Naeher; Lynn E Copes; Stefan Judex; Clinton T Rubin; Brigitte Demes
Journal:  J Exp Biol       Date:  2015-07-31       Impact factor: 3.312

2.  The bone regenerative capacity of canine mesenchymal stem cells is regulated by site-specific multilineage differentiation.

Authors:  Juan Bugueño; Weihua Li; Pinky Salat; Ling Qin; Sunday O Akintoye
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-09-28

Review 3.  Translating stem cell therapies: the role of companion animals in regenerative medicine.

Authors:  Susan W Volk; Christine Theoret
Journal:  Wound Repair Regen       Date:  2013-04-29       Impact factor: 3.617

Review 4.  Manufacturing Mesenchymal Stromal Cells for the Treatment of Osteoarthritis in Canine Patients: Challenges and Recommendations.

Authors:  Ana Ivanovska; Mengyu Wang; Tarlan Eslami Arshaghi; Georgina Shaw; Joel Alves; Andrew Byrne; Steven Butterworth; Russell Chandler; Laura Cuddy; James Dunne; Shane Guerin; Rob Harry; Aidan McAlindan; Ronan A Mullins; Frank Barry
Journal:  Front Vet Sci       Date:  2022-06-10

5.  Type III collagen regulates osteoblastogenesis and the quantity of trabecular bone.

Authors:  Susan W Volk; Shalin R Shah; Arthur J Cohen; Yanjian Wang; Becky K Brisson; Laurie K Vogel; Kurt D Hankenson; Sherrill L Adams
Journal:  Calcif Tissue Int       Date:  2014-03-14       Impact factor: 4.333

6.  A canine in vitro model for evaluation of marrow-derived mesenchymal stromal cell-based bone scaffolds.

Authors:  Tanmay P Gharat; Patricia Diaz-Rodriguez; Josh D Erndt-Marino; Andrea Carolina Jimenez Vergara; Dany J Munoz Pinto; Robert N Bearden; Shannon S Huggins; Melissa Grunlan; W Brian Saunders; Mariah S Hahn
Journal:  J Biomed Mater Res A       Date:  2018-05-14       Impact factor: 4.396

7.  Optimizing In Vitro Osteogenesis in Canine Autologous and Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells with Dexamethasone and BMP-2.

Authors:  Shelby B Gasson; Lauren K Dobson; Lyndah Chow; Steven Dow; Carl A Gregory; William Brian Saunders
Journal:  Stem Cells Dev       Date:  2021-02-08       Impact factor: 3.272

8.  Acupoint injection of autologous stromal vascular fraction and allogeneic adipose-derived stem cells to treat hip dysplasia in dogs.

Authors:  Camila Marx; Maiele Dornelles Silveira; Isabel Selbach; Ariel Silveira da Silva; Luisa Maria Gomes de Macedo Braga; Melissa Camassola; Nance Beyer Nardi
Journal:  Stem Cells Int       Date:  2014-08-11       Impact factor: 5.443

9.  Characterization and Immunomodulatory Effects of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells.

Authors:  Keith A Russell; Natalie H C Chow; David Dukoff; Thomas W G Gibson; Jonathan LaMarre; Dean H Betts; Thomas G Koch
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 10.  Clinical application of mesenchymal stem cells therapy in musculoskeletal injuries in dogs-a review of the scientific literature.

Authors:  Inês E Dias; Diogo F Cardoso; Carla S Soares; Luís C Barros; Carlos A Viegas; Pedro P Carvalho; Isabel R Dias
Journal:  Open Vet J       Date:  2021-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.